Skip to content

Climb Bio, Inc.

CLYM

CIK 0001768446

← back to feed
Revenue (TTM)
—
Q1 Apr 2026
Net Income (TTM)
−$56.06M
+19.0% YoY Q1 Apr 2026
EPS Diluted (TTM)
−$0.83
+42.5% YoY Q1 Apr 2026
Gross Margin
—
Q1 Apr 2026
Operating Margin
—
Q1 Apr 2026
Net Margin
—
Q1 Apr 2026
Free Cash Flow (TTM)
−$47M
Q1 Apr 2026
Cash
$8.36M
Q1 Apr 2026
Total Debt
—
Q1 Apr 2026
Shares Outstanding
57.26M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings